Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Edwards Lifesciences Corporation EW
$88.73
-$0.06 (-0.06%)
На 18:00, 12 мая 2023
+28.75%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
53656353764.00000000
-
week52high
107.92
-
week52low
67.13
-
Revenue
5382400000
-
P/E TTM
36
-
Beta
1.01349400
-
EPS
2.41000000
-
Last Dividend
0.00000000
-
Next Earnings Date
26 июл 2023 г. в 10:59
Описание компании
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Raymond James | Outperform | Outperform | 29 июл 2022 г. |
| Piper Sandler | Overweight | Overweight | 29 июл 2022 г. |
| Citigroup | Buy | Buy | 29 июл 2022 г. |
| Canaccord Genuity | Hold | Buy | 29 июл 2022 г. |
| Truist Securities | Buy | Buy | 20 июл 2022 г. |
| Truist Securities | Buy | Buy | 22 сент 2022 г. |
| Barclays | Overweight | 18 окт 2022 г. | |
| Canaccord Genuity | Hold | Hold | 14 окт 2022 г. |
| Jefferies | Buy | 12 окт 2022 г. | |
| Morgan Stanley | Overweight | Overweight | 11 окт 2022 г. |
| Wells Fargo | Overweight | Overweight | 28 окт 2022 г. |
| Truist Securities | Buy | Buy | 28 окт 2022 г. |
| RBC Capital | Outperform | Outperform | 28 окт 2022 г. |
| Morgan Stanley | Overweight | Overweight | 28 окт 2022 г. |
| Raymond James | Outperform | Outperform | 31 окт 2022 г. |
| Goldman Sachs | Neutral | Neutral | 03 ноя 2022 г. |
| Mizuho | Buy | Buy | 07 дек 2022 г. |
| Stifel | Hold | Buy | 06 дек 2022 г. |
| Wolfe Research | Peer Perform | Outperform | 02 дек 2022 г. |
| RBC Capital | Outperform | Outperform | 28 ноя 2022 г. |
| Morgan Stanley | Overweight | Overweight | 06 янв 2023 г. |
| Raymond James | Outperform | Outperform | 13 дек 2022 г. |
| Citigroup | Buy | Buy | 12 дек 2022 г. |
| Truist Securities | Buy | Buy | 01 февр 2023 г. |
| Canaccord Genuity | Hold | Hold | 01 февр 2023 г. |
| Piper Sandler | Neutral | Overweight | 30 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Chopra Daveen | D | 8435 | 4000 | 17 янв 2023 г. |
| Chopra Daveen | D | 18911 | 4000 | 17 янв 2023 г. |
| Chopra Daveen | A | 22911 | 4000 | 17 янв 2023 г. |
| MUSSALLEM MICHAEL A | D | 117500 | 29375 | 13 янв 2023 г. |
| MUSSALLEM MICHAEL A | A | 3482517 | 9500 | 13 янв 2023 г. |
| MUSSALLEM MICHAEL A | D | 157353 | 19875 | 13 янв 2023 г. |
| MUSSALLEM MICHAEL A | D | 177228 | 9500 | 13 янв 2023 г. |
| MUSSALLEM MICHAEL A | A | 186728 | 29375 | 13 янв 2023 г. |
| BOBO DONALD E JR | D | 20175 | 6725 | 09 янв 2023 г. |
| BOBO DONALD E JR | D | 62561 | 6725 | 09 янв 2023 г. |
Новостная лента
3 Medical Device Stocks Outpacing the Healthcare Industry This Year
The Motley Fool
01 мая 2023 г. в 06:30
Medtronic has raised its dividend for 45 consecutive years. Edwards Lifesciences had a strong first quarter and upgraded 2023 guidance.
ALC or EW: Which Is the Better Value Stock Right Now?
Zacks Investment Research
28 апр 2023 г. в 12:56
Investors interested in Medical - Instruments stocks are likely familiar with Alcon (ALC) and Edwards Lifesciences (EW). But which of these two stocks is more attractive to value investors?
Edwards Lifesciences (EW) Q1 Earnings Top Estimates, '23 View Up
Zacks Investment Research
27 апр 2023 г. в 11:27
Edwards Lifesciences (EW) continues to register strong momentum in TMTT, led by the continued adoption of the PASCAL Precision system in Europe.
Edwards Lifesciences Corporation (EW) Q1 2023 Earnings Call Transcript
Seeking Alpha
26 апр 2023 г. в 20:43
Edwards Lifesciences Corporation (EW) Q1 2023 Earnings Call Transcript.
Edwards Lifesciences (EW) Beats Q1 Earnings and Revenue Estimates
Zacks Investment Research
26 апр 2023 г. в 18:59
Edwards Lifesciences (EW) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.61 per share. This compares to earnings of $0.60 per share a year ago.